Timothy R. Wright - Mar 25, 2024 Form 4 Insider Report for Protagenic Therapeutics, Inc.\new (PTIX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTIX	PTIX Common stock Options	Award	$37K	+21.3K		$1.74	21.3K	Mar 25, 2024	PTIX Common Stock, Par Value $0.0001	21.3K	$1.74	Direct

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

The options vest monthly over 24 months, commencing upon the date of grant, with full acceleration upon a change of control.